The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AUGMENT: A randomized, phase 3 trial in patients with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) to compare efficacy and safety of lenalidomide plus rituximab (R2) versus placebo plus rituximab.
 
John Leonard
Consulting or Advisory Role - Celgene; Genentech
 
John G. Gribben
Honoraria - Celgene; Gilead Sciences; Janssen; Pharmacyclics; Roche Pharma AG
Travel, Accommodations, Expenses - Gilead Sciences
 
Marek Trněný
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Phillip Scheinberg
No Relationships to Disclose
 
Kensei Tobinai
Research Funding - Celgene
 
Nathan Hale Fowler
Consulting or Advisory Role - Celgene; Gilead Sciences; Pharmacyclics; Roche Pharma AG
Research Funding - Celgene; Gilead Sciences; Pharmacyclics; Roche Pharma AG
 
Nurgul Kilavuz
Employment - Celgene
Leadership - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Pierre Fustier
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Barbara Amoroso
Employment - Celgene
Consulting or Advisory Role - Celgene